MedMira (MedMira) Short-Term Capital Lease Obligation : $0.13 Mil (As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is MedMira Short-Term Capital Lease Obligation?

MedMira's Short-Term Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.13 Mil.

MedMira's quarterly Short-Term Capital Lease Obligation declined from Jul. 2023 ($0.13 Mil) to Oct. 2023 ($0.13 Mil) but then increased from Oct. 2023 ($0.13 Mil) to Jan. 2024 ($0.13 Mil).

MedMira's annual Short-Term Capital Lease Obligation increased from Jul. 2021 ($0.12 Mil) to Jul. 2022 ($0.12 Mil) and increased from Jul. 2022 ($0.12 Mil) to Jul. 2023 ($0.13 Mil).

MedMira Short-Term Capital Lease Obligation Historical Data

The historical data trend for MedMira's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Short-Term Capital Lease Obligation Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.10

0.12

0.13

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.12	0.12	0.13	0.13	0.13

MedMira Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

MedMira Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of MedMira's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.